PE Anti-Human CD133 Antibody[W6B3C1]

The PE Anti-Human CD133 Antibody [W6B3C1] is a highly reliable and efficient tool designed for the detection and analysis of CD133 expression in human samples. This antibody, conjugated with phycoerythrin (PE), offers exceptional sensitivity and specificity, enabling accurate identification and characterization of CD133-positive cells.

The CD133 antigen, also known as prominin-1, is a transmembrane glycoprotein that has been widely recognized as a marker for various stem and progenitor cell populations. Its expression has been observed in numerous tissues, including hematopoietic stem cells, neural stem cells, and cancer stem cells. The PE Anti-Human CD133 Antibody [W6B3C1] specifically recognizes the extracellular domain of CD133, allowing for precise detection and quantification of CD133-positive cells.

This antibody has been extensively validated for flow cytometry applications, ensuring consistent and reproducible results. Its exceptional performance characteristics, such as low background staining and high signal-to-noise ratio, make it an ideal choice for various research and clinical applications. Whether investigating stem cell biology, cancer research, or regenerative medicine, the PE Anti-Human CD133 Antibody [W6B3C1] provides researchers with a powerful tool to advance their studies.

Furthermore, this antibody is manufactured under stringent quality control standards, ensuring batch-to-batch consistency and reliability. It is supplied in a convenient format, ready-to-use for flow cytometry experiments. The PE conjugation enhances the detection sensitivity, allowing for accurate identification of CD133-positive cells even at low expression levels.

In summary, the PE Anti-Human CD133 Antibody [W6B3C1] is a highly specific and sensitive reagent that enables precise detection and analysis of CD133 expression in human samples. Its exceptional performance characteristics, combined with its reliable manufacturing process, make it an indispensable tool for researchers and clinicians in various fields of study.